A large-scale global study has identified genetic variants that are risk factors for long COVID, a discovery that helps researchers better understand the biological systems involving the disease and ...

Ensitrelvir marks a breakthrough in anti-COVID treatment, paving the way for future defenses against betacoronaviruses.

Long COVID affects up to 18 million Americans, yet research funding remains inadequate. Experts call for aggressive NIH investment in novel treatments.

Turns out, Chronic Fatigue Syndrome (CFS) and long Covid have a few things in common. For one, they're notoriously tricky to diagnose. So when researchers said they developed a blood test that may be ...

Heterogeneous long COVID definitions across CDC, NASEM, and studies create downstream effects on diagnosis thresholds, treatment pathways, and outcome measurement, undermining equity and research ...

Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms. The medications are currently being ...

Not long ago, we were all masters of covid math. When the pandemic began in 2020, the number stuck in our minds was 14: If we (or any close contact) got a positive COVID-19 test, we were supposed to ...

Experts aren't quite sure what's in store for us this cold, flu and COVID season. But with a new flu variant beginning to spread in the U.S. and low COVID vaccination rates, this may be a more severe ...

Long COVID can linger long after the acute infection ends. People report fatigue, brain fog, dizziness, and poor sleep. Many struggle to work or manage basic chores. Some crash after small efforts, ...